Thomas A. Nemcek

AbbVie (United States)

Papers

2

Total Citations

60

H-Index

2

About

Thomas A. Nemcek is a pioneer in the automation of pharmaceutical chemistry, whose work has fundamentally reshaped how drug candidates are synthesized and processed. His primary research focus lies at the intersection of organic synthesis, flow chemistry, and high-throughput automation, where he has engineered integrated platforms that dramatically accelerate the drug discovery pipeline. Nemcek’s landmark contribution is the development of a flexible, fully automated synthesis–purification–sample-management platform, which leverages a Mitsubishi robot to seamlessly link flow chemistry with compound generation and management. This system, detailed in his most-cited paper (2013, 36 citations), enables the rapid production of small-molecule drug candidates, reducing manual intervention and increasing throughput. Additionally, he constructed and validated an automated flow hydrogenation instrument (2007, 24 citations) by coupling a Bohdan robot with a ThalesNano H-cube hydrogenator, demonstrating his skill in merging robotics with catalytic reactions for high-throughput organic chemistry. With these innovations, Nemcek has provided the pharmaceutical industry with scalable, reproducible tools that enhance efficiency and accelerate the journey from synthesis to clinical testing, making him a key figure in modern medicinal chemistry automation.

Research Focus

Key Achievements

2
H-Index
2
Papers
60
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
An Automated Synthesis–Purification–Sample-Management Platform for the Accelerated Generation of Pharmaceutical Candidates
36 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: AbbVie (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago